(1)
Improving BNT162b2 MRNA Vaccine Tolerability Without Efficacy Loss by Pidotimod Supplementation: Pidotimod in SARS-CoV-2 Vaccination. Mediterr J Hematol Infect Dis 2022, 14 (1), e2022023. https://doi.org/10.4084/MJHID.2022.023.